Signaturefd LLC reduced its stake in shares of Tilray Brands, Inc. (NASDAQ:TLRY – Free Report) by 91.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,160 shares of the company’s stock after selling 105,264 shares during the quarter. Signaturefd LLC’s holdings in Tilray Brands were worth $92,000 at the end of the most recent quarter.
A number of other institutional investors have also recently added to or reduced their stakes in the stock. Integrated Wealth Concepts LLC grew its stake in Tilray Brands by 33.8% during the 3rd quarter. Integrated Wealth Concepts LLC now owns 36,977 shares of the company’s stock worth $64,000 after buying an additional 9,341 shares during the last quarter. CreativeOne Wealth LLC grew its stake in Tilray Brands by 12.2% during the 3rd quarter. CreativeOne Wealth LLC now owns 87,134 shares of the company’s stock worth $151,000 after buying an additional 9,452 shares during the last quarter. Dudley Capital Management LLC grew its stake in Tilray Brands by 73.3% during the 3rd quarter. Dudley Capital Management LLC now owns 26,000 shares of the company’s stock worth $45,000 after buying an additional 11,000 shares during the last quarter. Arizona State Retirement System boosted its position in Tilray Brands by 4.3% during the 3rd quarter. Arizona State Retirement System now owns 307,193 shares of the company’s stock worth $531,000 after acquiring an additional 12,675 shares during the period. Finally, Brighton Jones LLC grew its stake in shares of Tilray Brands by 28.3% in the third quarter. Brighton Jones LLC now owns 59,510 shares of the company’s stock worth $103,000 after purchasing an additional 13,137 shares in the last quarter. 9.35% of the stock is currently owned by institutional investors.
Tilray Brands Stock Performance
NASDAQ:TLRY opened at $6.57 on Monday. Tilray Brands, Inc. has a 1 year low of $3.51 and a 1 year high of $23.20. The stock has a market cap of $765.73 million, a price-to-earnings ratio of -0.48 and a beta of 2.00. The business has a fifty day moving average of $7.13 and a 200-day moving average of $9.96. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.66 and a current ratio of 2.79.
Analysts Set New Price Targets
Several research analysts have recently issued reports on TLRY shares. Canaccord Genuity Group started coverage on Tilray Brands in a research note on Tuesday, January 27th. They issued a “hold” rating for the company. Roth Mkm raised Tilray Brands from a “neutral” rating to a “buy” rating and set a $10.00 price target for the company in a research note on Thursday, April 2nd. TD Cowen decreased their price target on Tilray Brands from $10.00 to $7.00 and set a “buy” rating for the company in a research note on Monday, March 30th. Zacks Research raised Tilray Brands from a “strong sell” rating to a “hold” rating in a research note on Wednesday, February 11th. Finally, Wall Street Zen raised Tilray Brands from a “sell” rating to a “hold” rating in a research note on Saturday, March 21st. Three analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $11.50.
Tilray Brands Profile
Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.
Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.
See Also
Want to see what other hedge funds are holding TLRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tilray Brands, Inc. (NASDAQ:TLRY – Free Report).
Receive News & Ratings for Tilray Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray Brands and related companies with MarketBeat.com's FREE daily email newsletter.
